Ken Griffin Sop Hi A Genetics Sa Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Citadel Advisors LLC holds 12,320 shares of SOPH stock, worth $52,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,320
Previous 39,111
68.5%
Holding current value
$52,852
Previous $121,000
52.89%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SOPH
# of Institutions
43Shares Held
19.9MCall Options Held
0Put Options Held
0-
Generation Investment Management LLP London, X06.79MShares$29.1 Million0.21% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va3.72MShares$16 Million0.2% of portfolio
-
Banque Pictet & Cie Sa2.21MShares$9.47 Million0.06% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$9.3 Million0.01% of portfolio
-
Alta Wealth Advisors LLC1.41MShares$6.05 Million2.38% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $275M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...